SCHEMBL28528987

SCHEMBL28528987

CNC1CCN(c2ccc([N+](=O)[O-])cc2OC(C)C)CC1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.49
ADRA1D P25100 2/20 0.49
ADRA1A P35348 2/20 0.49
ADRA1B P35368 2/20 0.49
MAPT P10636 2/20 0.47
CYP19A1 P11511 2/20 0.46
HTT P42858 1/20 0.45
ALDH1A1 P00352 8/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 3/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
RXFP1 Q9HBX9 1/20 0.42
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28525391 0.88 DRD2 (0.47) DRD2ADRA1DADRA1AADRA1BMAPT
SCHEMBL28532300 0.87 ALDH1A1 (0.55) DRD2ADRA1DADRA1AADRA1BMAPT
SCHEMBL28518939 0.84 SMN1; SMN2 (0.48) MAPTHTTALDH1A1SMN1; SMN2LMNA
SCHEMBL28520443 0.84 CYP19A1 (0.48) DRD2ADRA1DADRA1AADRA1BMAPT
SCHEMBL2912296 0.82 ALDH1A1 (0.52) MAPTCYP19A1HTTALDH1A1SMN1; SMN2
SCHEMBL28526104 0.82 ALDH1A1 (0.48) DRD2ADRA1DADRA1AADRA1BMAPT
SCHEMBL28525574 0.81 DRD2 (0.42) DRD2ADRA1DADRA1AADRA1BMAPT
SCHEMBL20242265 0.81 ALDH1A1 (0.57) MAPTHTTALDH1A1SMN1; SMN2LMNA
Ammonia Solution, Strong SCHEMBL3878149 0.81 ALDH1A1 (0.51) MAPTCYP19A1HTTALDH1A1SMN1; SMN2
SCHEMBL28523902 0.81 ALDH1A1 (0.60) DRD2ADRA1DADRA1AADRA1BMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111836819-A Arylamine-substituted pyrrolopyrimidine compound, and preparation method and application thereof 北京赛特明强医药科技有限公司 2020-10-27 CN disclosed